HRP20170379T1 - Postupak proizvodnje naltreksona - Google Patents

Postupak proizvodnje naltreksona Download PDF

Info

Publication number
HRP20170379T1
HRP20170379T1 HRP20170379TT HRP20170379T HRP20170379T1 HR P20170379 T1 HRP20170379 T1 HR P20170379T1 HR P20170379T T HRP20170379T T HR P20170379TT HR P20170379 T HRP20170379 T HR P20170379T HR P20170379 T1 HRP20170379 T1 HR P20170379T1
Authority
HR
Croatia
Prior art keywords
process according
noroxymorphone
mixture
reaction
mixing
Prior art date
Application number
HRP20170379TT
Other languages
English (en)
Croatian (hr)
Inventor
Carla De Faveri
Florian Anton Martin Huber
Mariano Stivanello
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of HRP20170379T1 publication Critical patent/HRP20170379T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HRP20170379TT 2010-11-05 2011-11-04 Postupak proizvodnje naltreksona HRP20170379T1 (hr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US41040510P 2010-11-05 2010-11-05
DKPA201001007 2010-11-05
US201161489701P 2011-05-25 2011-05-25
DKPA201100396 2011-05-25
PCT/DK2011/000128 WO2012059103A1 (en) 2010-11-05 2011-11-04 Method for the manufacturing of naltrexone
EP11785301.0A EP2635586B1 (en) 2010-11-05 2011-11-04 Method for the manufacturing of naltrexone

Publications (1)

Publication Number Publication Date
HRP20170379T1 true HRP20170379T1 (hr) 2017-05-05

Family

ID=45001588

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20170379TT HRP20170379T1 (hr) 2010-11-05 2011-11-04 Postupak proizvodnje naltreksona

Country Status (20)

Country Link
EP (1) EP2635586B1 (enExample)
JP (2) JP6246589B2 (enExample)
AP (1) AP3415A (enExample)
AU (1) AU2011325563B2 (enExample)
CA (1) CA2815093C (enExample)
CY (1) CY1118742T1 (enExample)
DK (1) DK2635586T3 (enExample)
EA (1) EA022266B1 (enExample)
ES (1) ES2620660T3 (enExample)
HR (1) HRP20170379T1 (enExample)
HU (1) HUE033596T2 (enExample)
LT (1) LT2635586T (enExample)
ME (1) ME02621B (enExample)
MX (1) MX2013005009A (enExample)
PL (1) PL2635586T3 (enExample)
PT (1) PT2635586T (enExample)
RS (1) RS55777B1 (enExample)
SI (1) SI2635586T1 (enExample)
SM (1) SMT201700177T1 (enExample)
WO (1) WO2012059103A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140005216A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
AR096851A1 (es) 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno
KR20160093025A (ko) 2013-12-20 2016-08-05 하. 룬트벡 아크티에 셀스카브 멜랑코리성 특색을 갖는 우울 장애의 치료를 위한 카파-활성을 갖는 오피오이드 수용체 길항제 및 보티옥세틴의 용도
JP6797691B2 (ja) 2014-04-22 2020-12-09 大塚製薬株式会社 ブレクスピプラゾールとナルメフェンの組み合わせ剤及び物質関連障害を治療するためのその用途
US9701687B2 (en) * 2014-05-05 2017-07-11 Noramco, Inc. Process for the preparation of opioid compounds
US9701688B2 (en) * 2014-05-05 2017-07-11 Noramco, Inc. Process for the preparation of opioid compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
ATE178329T1 (de) * 1989-10-16 1999-04-15 Us Health Totale synthese von northebain-, normorphin-, noroxymorphon-enantiomeren und -derivaten via n- nor-zwischenverbindungen
FR2906252B1 (fr) * 2006-09-21 2008-11-28 Sanofi Aventis Sa Procede de preparation d'halogenures de n-aklyl naltrexone
WO2008138383A1 (de) 2007-05-16 2008-11-20 Cilag Ag Verfahren zur herstellung von n-methylnaltrexonbromid
CN102227433B (zh) * 2008-09-30 2015-01-07 马林克罗特有限公司 烷基化吗啡喃衍生物的仲胺基团的方法
PL2435439T3 (pl) 2009-05-25 2016-05-31 H Lundbeck As Wytwarzanie chlorowodorku nalmefenu z naltreksonu

Also Published As

Publication number Publication date
EP2635586B1 (en) 2017-02-08
HUE033596T2 (hu) 2017-12-28
JP2016199566A (ja) 2016-12-01
EA022266B1 (ru) 2015-11-30
PL2635586T3 (pl) 2017-06-30
CA2815093A1 (en) 2012-05-10
AP2013006897A0 (en) 2013-05-31
MX2013005009A (es) 2013-08-01
LT2635586T (lt) 2017-04-10
AP3415A (en) 2015-09-30
EP2635586A1 (en) 2013-09-11
JP6246589B2 (ja) 2017-12-13
PT2635586T (pt) 2017-03-30
AU2011325563B2 (en) 2015-08-20
JP2013541564A (ja) 2013-11-14
JP6215399B2 (ja) 2017-10-18
RS55777B1 (sr) 2017-07-31
SI2635586T1 (sl) 2017-07-31
ME02621B (me) 2017-06-20
AU2011325563A1 (en) 2013-05-02
CA2815093C (en) 2019-08-06
CY1118742T1 (el) 2017-07-12
EA201390658A1 (ru) 2013-11-29
WO2012059103A1 (en) 2012-05-10
ES2620660T3 (es) 2017-06-29
SMT201700177T1 (it) 2017-05-08
DK2635586T3 (en) 2017-03-27

Similar Documents

Publication Publication Date Title
HRP20170379T1 (hr) Postupak proizvodnje naltreksona
JP2016520038A5 (enExample)
ME02458B (me) Postupci i intermedijeri za spravljanje jak inhibitora
MY167395A (en) Method for producing glufosinate p free acid
AR076891A1 (es) Metodo para la preparacion de clorhidrato de nalmefeno
RU2015145732A (ru) Способ получения гидроксида 1-адамантилтриметиламмония
CO6310992A2 (es) Metodo para preparar chalconas de 3-trifluorometilo
EA201490831A1 (ru) Способ получения хинолиновых производных
HRP20231424T1 (hr) Postupak proizvodnje kalijevog acesulfama
HRP20220201T1 (hr) Postupak za pripremu pleuromutilina
EP2631253A3 (en) Preparation of polymer, resulting polymer, resist composition, and patterning process
RU2013110775A (ru) Бутиловый иономерный латекс
GB2505859A8 (en) Aripiprazole type I microcrystal, aripiprazole solid preparation, and preparation method
AR088296A1 (es) Citramida de rasagilina, proceso de preparación y composicion farmaceutica
JP2013541564A5 (enExample)
HRP20150616T1 (hr) Postupci za pripremu spoja prolijeka inhibitora vezanja hiv-a i intermedijera
MX351176B (es) Método para producir y purificar sales del ácido acrilamido-2- metilpropan sulfónico.
HRP20161519T1 (hr) Postupci za proizvodnju sredstava protiv gljivica
HRP20161031T1 (hr) POSTUPCI ZA PRIPREMANJE (3R,3aS,6aR) HEKSAHIDRO-FURO[2,3-b]FURAN-3-OLA
CN103086992A (zh) 六甲氧基甲基三聚氰胺树脂制备方法
HRP20170023T1 (hr) Kristalni oblik pemirolasta
MX2016001199A (es) Proceso para preparar rifaximina kappa.
WO2012164242A8 (en) Process for the preparation of paliperidone
HRP20191632T1 (hr) Kemijski postupak dobivanja spiroindolona i njihovih međuprodukata
HRP20220108T1 (hr) Postupak za proizvodnju vortioksetina hbr alfa-oblika